Doc's note: Everyone knows Tesla as a leader in self-driving vehicles. But all of those years of data gathering for its cars have led Tesla to the next frontier in AI innovation – humanoid robots, as tech expert Jeff Brown (from our corporate affiliate Brownstone Research) explains...

One of Tesla's (TSLA) key advantages in the autonomous-driving industry has been its data repository of real-world video, which it used to train its Full Self-Driving ("FSD") software.

Both the repository and Tesla's strategy for collecting that data distinguish it from its competitors.

You see, Tesla has designed and manufactured all of its electric vehicles ("EVs") with self-driving capabilities.

Every new Tesla EV comes with an FSD computer and cameras to capture a 360-degree view of its driving conditions.

Naturally, this increases the cost of manufacturing each EV. But having AI hardware at the ready in every EV enables Tesla to upsell many of its customers to self-driving software after their initial purchase or lease.

And as I'll explain, the real value Tesla has generated is the ability to collect vast amounts of real-world data...

Building the Data Foundation

This all began shortly after Tesla installed its Autopilot systems into EVs in late 2014. It was the less-advanced software that preceded FSD.

That's how, prior to FSD, Tesla managed to collect about 9 billion miles' worth of data from the millions of Teslas already on the road.

When a driver returned home, their EV would connect to Wi-Fi and automatically upload the data from their trip to Tesla. Those 9 billion miles became the foundation for the early training of Tesla's vision-based FSD software.

And as Tesla's "fleet" of EVs capable of autonomous driving got more advanced, its data-collection efforts grew.

Tesla has now collected around 17 billion miles' worth of FSD data... 6.8 billion of them from urban environments.

By way of comparison, Alphabet's Waymo autonomous vehicles have collected data on only 300 million autonomous miles. That's about 1.8% of Tesla's total.

This is one of the key reasons that Tesla's Cybercabs and Robotaxis are so incredible. Those ride-hailing services use the same FSD software as Tesla's other vehicles.

And this software also became the foundation for Tesla's humanoid robot – Optimus.

The Index of Autonomy

There are more parallels between EVs and robots than you might think. After all, a self-driving car is nothing more than a robot on four wheels...

Which raises the question: How can companies collect the data needed to train humanoid robots without millions of prototypes operating in the real world?

It's a classic chicken-or-the-egg problem. EVs are one thing... Even when they weren't intelligent and capable of autonomous driving, they could – and did – operate like normal cars and collect useful data.

But a humanoid robot without intelligence and knowledge of the real world would serve no purpose at all.

With FSD as a foundation – and thousands of Optimus robots now working in Tesla's offices and factories collecting data – Tesla has a major advantage in this market.

But what about other robotics companies?

Recently, I was excited to see an announcement made by leading humanoid-robotics firm Figure AI. It was about Index – its program to build "the world's largest and most diverse physical dataset."

Index had been kept under wraps for about four months before the program was made public. It's a clever way for Figure to solve its data problem.

Index is a smartphone app that enables users – or, as Figure calls them, Creators – to get paid for recording themselves performing tasks and uploading videos back to Figure.

Figure's Index App | Source: App Store @Figure INDEX

Figure creates a list of tasks that it wants to collect data on. Wearing the video-recording device Figure provides, Creators can earn income by simply completing chores throughout the day.

As of August, Figure had already paid out $15 million to Creators for their data-collection efforts. And in September, Figure's CEO announced that Index had crossed 86,000 weekly active users.

It's pretty impressive what Figure has done in only six months. It has already collected more than 22 million videos of real-world tasks. And it has established a broad reach.

Each point of light in the image below represents the location where a video has been collected...

Creators Video Uploads | Source: Figure AI

Figure has committed to spending $1 billion by August 2027 on data collection and computational resources to train its robots.

This is a massive sum for a startup that just formed in 2022. But it raised $1.5 billion in May 2025 in its Series C round, and it will almost certainly raise another large round within the next few months to continue accelerating growth.

Robots Will Walk Among Us

Robotics is a massive market opportunity worth trillions of dollars. Elon Musk has said that about 80% of Tesla's total value will one day be based on its Optimus business.

No other technology can easily solve labor shortages or transform labor markets, thereby improving quality of life on a global scale.

Industry, logistics, distribution, healthcare, agriculture, security, manufacturing, education, and many other sectors will be transformed by intelligent, general-purpose humanoid robots.

And the world will adopt them as quickly as they can be manufactured.

Mark my words: They will walk among us...

Regards,

Jeff Brown

Editor's note: Jeff believes the next generation of technology will have extreme consequences across society in the coming years. And a new class of companies will arise that can do things far beyond anything we've seen yet... and could create wealth a lot faster than folks realize, from just a small investment.

Click here to learn how before it begins on November 5.

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top